½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting



»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > СÊó¿¹NDUFB9µ¥¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • СÊó¿¹NDUFB9µ¥¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW7358
    • Ó¦Óà : ½öÏÞÓÚ¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£ºÐ¡Êó¿¹NDUFB9µ¥¿Ë¡¿¹Ìå

Ó¢ÎÄÃû³Æ£º Anti-NDUFB9 mouse monoclonal antibody

±ð       Ãû£º B22; CI-B22; LYRM3; UQOR22

Ïà¹ØÀà±ð£º Ò»¿¹

´¢       ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â

ËÞ       Ö÷£º Mouse

¿¹       Ô­£º NDUFB9

·´Ó¦ÖÖÊô£º Human

±ê  ¼Ç  Î Unconjugate

¿Ë¡ÀàÐÍ£º mouse monoclonal



¼¼Êõ¹æ¸ñ

Background:

The protein encoded by this gene is a subunit of the mitochondrial oxidative phosphorylation complex I (nicotinamide adenine dinucleotide: ubiquinone oxidoreductase). Complex I is localized to the inner mitochondrial membrane and functions to dehydrogenate nicotinamide adenine dinucleotide and to shuttle electrons to coenzyme Q. Complex I deficiency is the most common defect found in oxidative phosphorylation disorders and results in a range of conditions, including lethal neonatal disease, hypertrophic cardiomyopathy, liver disease, and adult-onset neurodegenerative disorders. Pseudogenes of this gene are found on chromosomes five, seven and eight. Alternative splicing results in multiple transcript variants.

Applications:

WB, IHC, FC

Name of antibody:

NDUFB9

Immunogen:

Fusion protein of human NDUFB9

Full name:

NADH:ubiquinone oxidoreductase subunit B9 (NDUFB9), transcript variant 1

Synonyms:

B22; CI-B22; LYRM3; UQOR22

SwissProt:

Q9Y6M9

IHC positive control:

human kidney tissue and carcinoma of human liver tissue

IHC Recommend dilution:

30-150

WB Predicted band size:

22 kDa

WB Positive control:

HepG2, Hela, A549, COS7, Jurkat, MCF-7 cell lysates

WB Recommended dilution:

500-2000

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿